z-logo
open-access-imgOpen Access
Ductal carcinoma in situ of the breasts: Over‐diagnosis, over‐treatment and a decade of lost direction
Author(s) -
Co Michael
Publication year - 2020
Publication title -
precision medical sciences
Language(s) - English
Resource type - Journals
ISSN - 2642-2514
DOI - 10.1002/prm2.12008
Subject(s) - ductal carcinoma , medicine , breast cancer , carcinoma in situ , incidence (geometry) , radiation therapy , in situ , carcinoma , oncology , cancer , radiology , physics , meteorology , optics
Ductal carcinoma in situ (DCIS) of the breast is the earliest detectable form of breast cancer. Mainstay of treatment is complete surgical removal with or without adjuvant radiotherapy. Incidence of DCIS has increased significantly over the last decade; however, increased surgical removal of DCIS has not resulted in the decreased incidence of invasive breast cancer. Whether or not we are over‐treating ductal carcinoma in situ (DCIS) with complete surgical removal of the tumor has been subjected to much debate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here